Liberia vs Togo: Antiretroviral therapy coverage for PMTCT
Liberia
88.0%
in 2024
Togo
87.0%
in 2024
Liberia rank
31st
Togo rank
33rd
Antiretroviral therapy coverage for PMTCT over time
- Liberia
- Togo
How they compare
Liberia currently reports 88.0% against 87.0% in Togo, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Togo ahead.
Liberia ranks 31st and Togo ranks 33rd of 84 countries.
Togo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 7.3% | 5.0% | Togo |
| 2010s | 40.8% | 83.4% | 42.6% | Togo |
| 2020s | 72.8% | 85.4% | 12.6% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Liberia or Togo?
- Liberia, at 88.0% against 87.0% in Togo as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Liberia and Togo?
- 1.0%, with Liberia ahead.
- How many years of comparable data are there for Liberia and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Liberia and Togo rank globally for antiretroviral therapy coverage for pmtct?
- Liberia ranks 31st and Togo ranks 33rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).